Coffee consumption and serum lipids: a randomized, crossover clinical trial

Area of Science:

• Cardiovascular Health
• Nutritional Science
• Clinical Trials

Background:

• Coffee is a widely consumed beverage globally.
• Concerns exist regarding coffee's impact on cardiovascular risk factors, specifically serum lipids.
• Filter-brewed coffee is a common preparation method, necessitating research into its specific health effects.

Purpose of the Study:

• To investigate the effect of consuming three or more cups of filter-brewed coffee daily on serum lipid profiles.
• To assess the impact on key atherogenic lipid markers.

Main Methods:

• A prospective, randomized crossover clinical trial involving 21 healthy white males.
• Participants consumed an average of 3.6 cups of filter-brewed coffee per day.
• Data analyzed using analysis of variance for repeated measures and paired t-tests, controlling for diet, creamer, and smoking.

Main Results:

• No statistically significant effect of filter-brewed coffee consumption was observed on serum total cholesterol.
• No impact was found on high-density lipoprotein (HDL) cholesterol levels.
• No adverse effect was detected on low-density lipoprotein (LDL) cholesterol or apolipoprotein B levels.

Conclusions:

• Moderate consumption of filter-brewed coffee does not adversely affect serum levels of atherogenic lipids in healthy individuals.
• Findings align with previous research indicating filtered coffee is safe concerning serum lipid profiles.
• This study has significant implications for public health, given coffee's popularity and ongoing concerns about heart disease risk factors.